“Durable Maintenance of EASI-90 With Amlitelimab in Adults With Moderate-to-Severe Atopic Dermatitis: 52-Week Results from the STREAM-AD Phase 2b Trial”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s606. Accessed April 20, 2026. https://skin.dermsquared.com/skin/article/view/3881.